Pelargonium
Presentation: Pelargonium 400 mg per capsule
Active constituents: Proanthocyanidin type, coumarins,
tannins and simple phenolic compounds
Directions: 2 capsules morning and
evening, to be taken with a glass of water. Children over the age of 6
years. (1 capsule a day) Not advised for pregnant women
Composition:
400 mg per capsule the root of cryoground Pelargonium powder.
Pelargonium sidoides has been recommended for the treatment of:
Respiratory infections
like bronchitis, sinusitis and pneumonia, tonsillitis and rhinopharyngitis.
It is often used as an alternative to antibiotics
Several clinical studies
Pelargonium on children· Study on 1042 children over 12, acute bronchitis: the response rate was 80% [LIS-BALCHIN, 2002]
· Study on 60 children, acute bronchitis Umckaloabo® is thus at least as effective as acetylcysteine [LIS-
BALCHIN, 2002]
· Double-blind study vs. placebo on 78 children for 6 days: after 4 days, the response rate was 90% for the Umckaloabo® treatment, against 44.7% for the placebo [LIS-BALCHIN, 2002]Clinical studies on adults
· On 641 adults, infections of the ORL system and the respiratory tract: after 14 days of treatment, 85% of patients were completely cured or showed a substantial improvement [LIS-BALCHIN, 2002]
· Double-blind study vs. placebo on 124 adults, acute bronchitis, at the end of the treatment (7days), the number of symptoms in patients treated with Umckaloabo® decreased to a greater extent than with the placebo [SCHWABE]
Mode of action
The
alcoholic extract of the Pelargonium roots has
been shown to have a three-way effect:
· Pelargonium Anti-bacterial: the p.sidoides extract prevents bacteria from sticking to cells
in the mucous membranes.
·
Pelargonium Antiviral effect: prevents viruses from attaching to the mucous
membrane cells and stimulates the body’s immune system in such a way that
both bacteria and viruses are prevented from multiplying
·
Pelargonium Expectorant: the extract acts as an expectorant,
allowing the body to expel contaminated mucous making conditions less
suitable for the multiplication of the bacteria and viruses.
Safety
During
14 days of Pelargonium treatment:
no side effect. [LIS-BALCHIN, on 2002].
Excellent ratio benefit/ risk for children as for adults. [ SCHWABE].
The cytotoxique potential of the product can be unimportant. [LIS-BALCHIN,
on 2002].
Restrictions of use of Pelargonium during
pregnancy and lactation
